These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 2655671)
1. Effects of naloxone and naltrexone on self-injury: a double-blind, placebo-controlled analysis. Barrett RP; Feinstein C; Hole WT Am J Ment Retard; 1989 May; 93(6):644-51. PubMed ID: 2655671 [TBL] [Abstract][Full Text] [Related]
2. A case report of naltrexone treatment of self-injury and social withdrawal in autism. Walters AS; Barrett RP; Feinstein C; Mercurio A; Hole WT J Autism Dev Disord; 1990 Jun; 20(2):169-76. PubMed ID: 2189867 [TBL] [Abstract][Full Text] [Related]
3. Operant analysis of human heroin self-administration and the effects of naltrexone. Mello NK; Mendelson JH; Kuehnle JC; Sellers MS J Pharmacol Exp Ther; 1981 Jan; 216(1):45-54. PubMed ID: 7452507 [TBL] [Abstract][Full Text] [Related]
4. The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study. Willemsen-Swinkels SH; Buitelaar JK; van Engeland H Biol Psychiatry; 1996 Jun; 39(12):1023-31. PubMed ID: 8780837 [TBL] [Abstract][Full Text] [Related]
5. Treatment of pruritus with topically applied opiate receptor antagonist. Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241 [TBL] [Abstract][Full Text] [Related]
6. Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior. Harris RA J Pharmacol Exp Ther; 1980 Jun; 213(3):497-503. PubMed ID: 6110766 [TBL] [Abstract][Full Text] [Related]
7. Resistance to change of alcohol self-administration: effects of alcohol-delivery rate on disruption by extinction and naltrexone. Jimenez-Gomez C; Shahan TA Behav Pharmacol; 2007 Mar; 18(2):161-9. PubMed ID: 17351423 [TBL] [Abstract][Full Text] [Related]
8. Punishment of self-injurious behavior using aromatic ammonia as the aversive stimulus. Tanner BA; Zeiler M J Appl Behav Anal; 1975; 8(1):53-7. PubMed ID: 1141081 [TBL] [Abstract][Full Text] [Related]
9. Naltrexone in treatment of self injurious behavior: a clinical study. Szymanski L; Kedesdy J; Sulkes S; Cutler A; Stevens-Our P Res Dev Disabil; 1987; 8(2):179-90. PubMed ID: 3671810 [TBL] [Abstract][Full Text] [Related]
10. [Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone]. Leboyer M; Bouvard MP; Launay JM; Recasens C; Plumet MH; Waller-Perotte D; Tabuteau F; Bondoux D; Dugas M Encephale; 1993; 19(2):95-102. PubMed ID: 8275903 [TBL] [Abstract][Full Text] [Related]
11. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial. Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403 [TBL] [Abstract][Full Text] [Related]
12. Limitations on the antagonistic actions of opioid antagonists. Young AM; Woods JH Fed Proc; 1982 May; 41(7):2333-8. PubMed ID: 7042396 [TBL] [Abstract][Full Text] [Related]